12 completed. 4 Phase 1, 4 Phase 3, 4 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 4 | Completed 4 |
| Phase 4 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Inflexal V: new trials by email Literature Review of Inflexal V trials Research Report on Inflexal V
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults Trivalent virosomal influenza vaccine, Commercial vaccine 1, Quadrivalent virosomal influenza vaccine - Influenza | Phase 1 | Completed | Crucell Holland BV | 240 | 2014-05-01 | 2014-10-24 |
| Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) Inflexal V - Influenza | Phase 3 | Completed | Crucell Holland BV | 110 | 2013-07-01 | 2013-08-30 |
| Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains Inflexal V - Influenza | Phase 3 | Completed | Crucell Holland BV | 110 | 2012-07-01 | 2013-12-20 |
| Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine Virosomal influenza vaccine - Influenza | Phase 1 | Completed | Crucell Holland BV | 84 | 2012-06-01 | 2014-08-20 |
| A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season Inflexal V - Influenza | Phase 4 | Completed | Crucell Holland BV | 52 | 2011-10-01 | 2013-02-20 |
| Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V Inflexal V - Influenza | Phase 3 | Completed | Crucell Holland BV | 205 | 2010-10-01 | 2014-02-06 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere Inflexal V - Influenza | Phase 4 | Completed | Crucell Holland BV | 110 | 2010-06-01 | 2013-09-09 |
| Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children Inflexal V, Agrippal - Influenza | Phase 3 | Completed | Crucell Holland BV | 1356 | 2009-10-01 | 2014-02-06 |
| A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents H1N1 pandemic influenza vaccine (whole virion, Vero cell-derived, inactivated), Seasonal trivalent influenza vaccine (licensed) for the season 2010/2011 - Influenza, Pandemic Influenza | Phase 1 / Phase 2 | Completed | Alachua Government Services, Inc. | 400 | 2009-09-01 | 2015-10-09 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere Inflexal V - Influenza | Phase 4 | Completed | Crucell Holland BV | 114 | 2009-06-01 | 2013-09-09 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere Inflexal V - Influenza | Phase 4 | Completed | Crucell Holland BV | 111 | 2008-07-01 | 2013-09-09 |
| Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania PEV 301& 302 in virosomes, Inflexal V (active comparator) - Falciparum Malaria | Phase 1 | Completed | Swiss Tropical & Public Health Institute | 50 | 2008-01-01 | 2013-03-15 |
Influenza, Human (11) · Virus Diseases (8) · Malaria (1) · Malaria, Falciparum (1)
Crucell Holland BV (10) · Alachua Government Services, Inc. (1) · Swiss Tropical & Public Health Institute (1)
Switzerland (5) · Belgium (2) · Italy (2) · Austria (1) · China (1) · Germany (1) · Tanzania (1)
Michael Seiberling, MD (4) · Blaise Genton, MD PhD (1) · Enza di Modugno (1) · Gian Vincenzo Zuccotti, Prof Dr (1) · Giancarlo Icardi, MD (1) · Milko Radicioni, MD (1) · Nicola Principi, Prof Dr (1) · Rongcheng Li, MD (1)
2014 (1)